Mutations in Bcl10 are very rare in colorectal cancer

• Published in: British journal of cancer 1999-07, Vol.80 (10), p.1569-1570
• Main Authors: Stone, J G, Rowan, A J, Tomlinson, I P M, Houlston, R S
• Format: Article
• Language: English
• Subjects: Adaptor Proteins, Signal Transducing; B-Cell CLL-Lymphoma 10 Protein; Biological and medical sciences; Biomedical and Life Sciences; Biomedicine; Cancer Research; Colorectal Neoplasms - genetics; Drug Resistance; Epidemiology; Gastroenterology. Liver. Pancreas. Abdomen; Humans; Medical sciences; Molecular Medicine; Mutation; Neoplasm Proteins - genetics; Oncology; Polymerase Chain Reaction; Polymorphism, Single-Stranded Conformational; Regular; regular-article; Stomach. Duodenum. Small intestine. Colon. Rectum. Anus; Tumor Cells, Cultured; Tumors
• ISSN: 0007-0920; 1532-1827
• DOI: 10.1038/sj.bjc.6690562

Summary Bcl10 is a recently identified gene reported to be involved commonly in human malignancy (Willis et al (1999) Cell 96: 1–20). To investigate whether it is frequently mutated in colorectal cancer we have analysed a series of 132 colorectal cancers and eight colorectal cancer cell lines for mutations in Bcl10 . One feature of the Bcl10 gene is that it harbours two polyadenine tracts. These repeating elements in genes can be prone to a high rate of mutation if there is defective mismatch repair. To examine the possibility that Bcl10 may be preferentially mutated in mismatch repair-deficient cancers, 49 of the tumours and cell lines were known to be replication error (RER)-positive and, of these, ten were from individuals harbouring germline mutations in hMLH1 or hMSH2 . No pathogenic mutations were detected in the tumours and only one mutation was found in the colorectal cancer cell lines. These results indicate that Bcl10 is unlikely to be involved in the pathways of colorectal carcinogenesis.